...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: PP

We should hear shortly wether the last Tranche of the 5mill Us has been taken up.It was supposed to close prior Aug 31 2020.

Share
New Message
Please login to post a reply